Inhibition of both aminopeptidase P and angiotensin-converting enzyme prevents bradykinin degradation in the rat coronary circulation

Journal of Cardiovascular Pharmacology

Volumn 30, Issue 1, 1997, Pages 96-101

  Erşahin, Çaǧatay ^a   Simmons, William H ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Aminopeptidase P; Angiotensin converting enzyme; Apstatin; Bradykinin; Coronary circulation

Indexed keywords

AMINOPEPTIDASE P; APSTATIN; BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE; RAMIPRILAT; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ENZYME ACTIVITY; ENZYME INHIBITION; HEART PROTECTION; METABOLISM; NONHUMAN; PRIORITY JOURNAL; RAT;

AMINOPEPTIDASES; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BRADYKININ; CORONARY CIRCULATION; CORONARY VESSELS; HYDROLYSIS; MALE; PEPTIDES; PEPTIDYL-DIPEPTIDASE A; PERFUSION; PROTEASE INHIBITORS; RAMIPRIL; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0041575002     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199707000-00014     Document Type: Article

References (38)

1. Linz W, Martorana PA, Schölkens BA. Local inhibition of bradykinin degradation in ischemic hearts. J Cardiovasc Pharmacol 1990;15(suppl 6):S99-109.
2. Zhu P, Zaugg CE, Simper D, Hornstein P, Allegrini PR, Buser PT. Bradykinin improves postischaemic recovery in the rat heart: role of high energy phosphates, nitric oxide, and prostacyclin. Cardiovasc Res 1995;29:658-63.
3. Martorana PA, Kettenbach B, Breipohl G, Linz W, Schölkens BA. Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist. Eur J Pharmacol 1990;182:395-6.
4. Vegh A, Szekers L, Parratt JR. Local intracoronary infusions of bradykinin profoundly reduce the severity of ischaemia-induced arrhythmias in anaesthetized dogs. Br J Pharmacol 1991;104:294-5.
5. Xiong W, Chen L-M, Woodley-Miller C, Simson JV, Chao J. Identification, purification, and localization of tissue kallikrein in rat heart. Biochem J 1990;267:639-46.
6. Nolly H, Carbini LA, Scicli G, Carretero OA, Scicli AG. A local kallikrein-kinin system is present in rat hearts. Hypertension 1994;23(pt. 2):919-23.
7. Baumgarten CR, Linz W, Kunkel G, Schölkens BA, Wiemer G. Ramiprilat increases bradykinin outflow from isolated hearts of rat. Br J Pharmacol 1993;108:293-5.
8. Linz W, Wiemer G, Gohlke P, Unger T, Schölkens BA. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev 1995;47:25-49.
9. Bönner G. Do kinins play a significant role in the antihypertensive and cardioprotective effects of angiotensin I-converting enzyme inhibitors? In: Laragh JH, Brenner BM, eds. Hypertension: pathophysiology, diagnosis, and management. 2nd ed. New York: Raven Press, 1995:2877-93.
10. Hartman JC, Wall TM, Hullinger TG, Shebuski RJ. Reduction of myocardial infarct size in rabbits by ramiprilat: reversal by the bradykinin antagonist HOE 140. J Cardiovasc Pharmacol 1993;21: 996-1003.
11. Ryan JW, Berryer P, Chung AYK, Sheffy DH. Characterization of rat pulmonary vascular aminopeptidase P in vivo: role in the inactivation of bradykinin. J Pharmacol Exp Ther 1994;269:941-7.
12. Prechel MM, Orawski AT, Maggiora LL, Simmons WH. Effect of a new aminopeptidase P inhibitor, apstatin, on bradykinin degradation in the rat lung. J Pharmacol Exp Ther 1995;275:1136-42.
13. Simmons WH, Orawski AT. Membrane-bound aminopeptidase P from bovine lung; its purification, properties, and degradation of bradykinin. J Biol Chem 1992;267:4897-903.
14. Orawski AT, Simmons WH. Purification and properties of membrane-bound aminopeptidase P from rat lung. Biochemistry 1995;34:11227-36.
15. Kitamura S-I, Carbini LA, Carretero OA, Simmons WH, Scicli AG. Potentiation by aminopeptidase P [inhibitor] of blood pressure response to bradykinin. Br J Pharmacol 1995;114:6-7.
16. Kitamura S-I, Carbini LA, Carretero OA, Simmons WH, Scicli AG. Effect of combined inhibition of angiotensin-converting enzyme and aminopeptidase P on hemodynamic response in severe hypertension [Abstract]. Hypertension 1995;26:554.
17. Erşahin Ç, Simmons WH. Bradykinin metabolism in the rat coronary circulation: role of aminopeptidase P and angiotensin converting enzyme [Abstract]. FASEB J 1996;10:A1017.
18. Orawski AT, Susz JP, Simmons WH. Aminopeptidase P from bovine lung: solubilization, properties, and potential role in bradykinin degradation. Mol Cell Biochem 1987;75:123-32.
19. Orawski AT, Susz JP, Simmons WH. Metabolism of bradykinin by multiple coexisting membrane-bound peptidases in lung: techniques for investigating the role of each peptidase using specific inhibitors. Adv Exp Biol Med 1989;247B:355-64.
20. Yoshimoto T, Orawski AT, Simmons WH. Substrate specificity of aminopeptidase P from Escherichia coli: comparison with membrane-bound forms from rat and bovine lung. Arch Biochem Biophys 1994;311:28-34.
21. Gay WA. Potassium-induced cardioplegia. Ann Thorac Surg 1975;20:95-100.
22. Sternbergh WC, Brunsting LA, Abd-Elfattah AS, Wechsler AS. Basal metabolic energy requirements of polarized and depolarized arrest in rat heart. Am J Physiol 1989;256:H846-51.
23. Gross DR. Animal models in cardiovascular research. 2nd rev. ed. Boston: Kluwer Academic, 1994:371. (Developments in cardiovascular medicine: vol 153).
24. Gross DR. Animal models in cardiovascular research. 2nd rev. ed. Boston: Kluwer Academic, 1994:371. (Developments in cardiovascular medicine: vol 153).
25. Döring HJ, Dehnart H. The isolated perfused heart according to Langendorff. 1st English ed. March, Germany: Biomesstechnik-Verlag, 1988:25-31.
26. Gafford JT, Skidgel RA, Erdos EG, Hersh LB. Human kidney "enkephalinase," a neutral metalloendopeptidase that cleaves active peptides. Biochemistry 1983;22:3265-71.
27. Matsas R, Kenny AJ, Turner AJ. The metabolism of neuropeptides: the hydrolysis of peptides, including enkephalin, tachykinins and their analogues, by endopeptidase-24.11. Biochem J 1984;223: 433-40.
28. Walter R, Simmons WH, Yoshimoto T. Proline specific endo- and exopeptidases. Mol Cell Biochem 1980;30:111-26.
29. Tisijar U. Thimet oligopeptidase - a review of a thiol dependent metallo-endopeptidase also known as Pz-peptidase, endopeptidase 24.15 and endo-oligopeptidase. Biol Chem Hoppe Selyer 1993; 374:91-100.
30. Ryan JW, Roblero J, Stewart JM. Inactivation of bradykinin in rat lung. Adv Exp Med Biol 1970;8:263-81.
31. Ryan JW. Peptidase enzymes of the pulmonary vascular surface. Am J Physiol 1989;257:L53-60.
32. Chen X, Orfanos SE, Ryan JW, Chung AYK, Hess DC, Catravas JD. Species variation in pulmonary endothelial aminopeptidase P activity. J Pharmacol Exp Ther 1991;259:1301-7.
33. Gräfe M, Auch-Schwelk W, Graf K, et al. Isolation and characterization of macrovascular and microvascular endothelial cells from human hearts. Am J Physiol 1994;267:H2138-48.
34. Ryan JW, Papapetropoulos A, Ju H, et al. Aminopeptidase P is disposed on human endothelial cells. Immunopharmacology 1996;32: 149-52.
35. Revann TR, Ryan JW, Berryer P, Valido F. Aminopeptidase P is disposed on guinea pig vascular endothelium and some epithelia [Abstract]. FASEB J 1991;5:A1579.
36. Kayar SR, Hoppeler H, Armstrong RB, et al. Estimating transit time for capillary blood in selected muscles of exercising animals. Pflugers Arch 1992;421:578-84.
37. 1 receptor antagonist on chronic cardiac response to coronary ligation in rats. Cardiovasc Res 1996;31:568-76.
38. Dendorfer A, Wellhoner P, Korsman K, Dominiak P. Degradation pathways for bradykinin and kallidin in isolated perfused rat heart. Poster, 14th International Symposium on Kinins. Denver, 1995;A62.